Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Ancient Genetic Fragments Reshape Cancer Genomes Years Before Diagnosis, Ushering in a New Era of Early Detection and Therapeutic Understanding
A groundbreaking study published in the prestigious journal Science has fundamentally reshaped our understanding of cancer evolution, revealing that ancient…
Read More
